VR to Evaluate Phantom Limb Pain

Sponsor
Shirley Ryan AbilityLab (Other)
Overall Status
Recruiting
CT.gov ID
NCT05915065
Collaborator
Coapt, LLC (Industry)
24
1
1
60
0.4

Study Details

Study Description

Brief Summary

The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity amputation.

We hypothesize that the system will improve PLP for individuals with upper or lower extremity amputation, as measured through with various outcome measures and questionnaires.

Detailed Description

The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the research setting and for at-home use by individuals with upper and lower extremity limb absence.

Phase 1: Complete in-lab or virtual iterative usability and functionality testing of hardware and software components of The Coapt Phantom Limb Pain Management System to ensure readiness for at-home use - COMPLETED

Phase 2: A clinical trial of The Coapt Phantom Limb Pain Management System during at-home use. We hypothesize that the system will improve PLP for individuals with upper or lower extremity absence, as measured through various questionnaires.

VR systems have been proposed as alternative technologies to treat PLP since they are relatively inexpensive and more readily available. Virtual reality environments allow for real-time control practice utilizing different tasks and games, and have been widely accepted as clinically viable options for administering therapy.

Effective PLP treatment methods are needed for individuals with limb absence that can be utilized on an as-needed basis in the home. VR therapy could potentially be an effective treatment for individuals with chronic upper or lower limb PLP.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
24 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
This study will enroll one, non-random group of amputees to participate in 2-4 in person or virtual research visits, participate in a home trial and complete questionnaires pre home trial, at various points during the home trial and upon conclusion of the home trial.This study will enroll one, non-random group of amputees to participate in 2-4 in person or virtual research visits, participate in a home trial and complete questionnaires pre home trial, at various points during the home trial and upon conclusion of the home trial.
Masking:
None (Open Label)
Primary Purpose:
Device Feasibility
Official Title:
Intuitively Controlled Virtual Reality to Treat Phantom Limb Pain
Actual Study Start Date :
Oct 1, 2020
Anticipated Primary Completion Date :
Sep 30, 2024
Anticipated Study Completion Date :
Sep 30, 2025

Arms and Interventions

Arm Intervention/Treatment
Other: Phantom Limb Pain Management System during at-home use.

Participants attend either in person at Shirley Ryan AbilityLab or virtually via Zoom Educational documents provided on pain and phantom limb pain. Participants are measured for an electrode cuff either in person or virtually Complete several questionnaires. Provided training on the Phantom Limb Pain Program with use of the electrode cuff and muscular contractions of their limb Participate in a 8 week home trial (1.5 hours per week of use, 20-40 minutes, 4-5x each week) Once home trial is complete - participants will be asked to participate in a phone or Zoom call at weeks 16,24 and 32 to repeat questionnaires.

Device: Coapt Phantom Limb Pain Management System
The PLP-MS consists of (1) an expandable arm/leg cuff with electrode sensors to collect EMG signals from residual limb muscles, (2) an integrated hardware module (the Coapt Complete Control Gen2.5 system) that translates users' EMG signals into game commands, (3) game software for mobile applications, and (4) a secure, HIPAA-compliant cloud-based data storage system for storing and retrieving user data remotely.

Outcome Measures

Primary Outcome Measures

  1. Short-form McGill Pain Questionnaire [Baseline score and at the post-treatment assessment at the end of the 8-week intervention]

    The primary outcome measure in this study is change in the pain rating index (PRI) between the baseline score and at the post-treatment assessment at the end of the 8-week intervention. The PRI is computed as the sum of the scores for all descriptors of the Short Form of the McGill Pain Questionnaire (SF-MPQ).

Secondary Outcome Measures

  1. Visual Analogue Scale (VAS) [Baseline score and at the post-treatment assessment at the end of the 8-week intervention]

    The pain VAS is a unidimensional measure of pain intensity, used to record a persons pain progression, or compare pain severity between paints with similar conditions.

  2. Numerical Pain Rating Scale (NPRS) [Baseline score and at the post-treatment assessment at the end of the 8-week intervention]

    The NPRS is a segmented numeric version of the visual analog scale (VAS) in which a respondent selects a whole number (0-10 integers) that best reflects the intensity of his/her pain.

  3. Patient-Reported Outcomes Measurement Information Systems (PROMIS) [Baseline score and at the post-treatment assessment at the end of the 8-week intervention]

    ROMIS® (Patient-Reported Outcomes Measurement Information System®) is a set of person-centered measures that evaluates and monitors physical, mental, and social health in adults. PROMIS measures can be used with the general population and with individuals living with chronic conditions.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Adults over the age of 18 years old

  • Amputation of the upper or lower limb, including amputation of multiple limbs

  • English Speaking

  • Chronic phantom limb pain (at least 6-months duration)

  • Average phantom limb pain intensity of 4 or greater on a 0-10 numerical rating scale

  • Average frequency of phantom limb pain episode of at least twice per month.

  • Residual limb pain of less than 5 on the Numerical Pain Rating Scale

  • Pain medication use stable for > 1 month

Exclusion Criteria

  • Unable to tolerate use of liner or cuff on their residual limb

  • Skin irritation/wounds on residual limb that would prevent use of the electrode cuff

  • Significant cognitive deficits or visual impairment that would preclude them from giving informed consent or following instructions during the experiments, or the ability to obtain relevant user feedback.

  • Non-English speaking

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shirley Ryan AbilityLab Chicago Illinois United States 60611

Sponsors and Collaborators

  • Shirley Ryan AbilityLab
  • Coapt, LLC

Investigators

  • Principal Investigator: Levi Hargrove, PhD, Shirley Ryan AbilityLab

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Levi Hargrove, Scientific Chair, Center for Bionic Medicine, Shirley Ryan AbilityLab
ClinicalTrials.gov Identifier:
NCT05915065
Other Study ID Numbers:
  • STU00213205
First Posted:
Jun 22, 2023
Last Update Posted:
Jun 22, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Levi Hargrove, Scientific Chair, Center for Bionic Medicine, Shirley Ryan AbilityLab
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 22, 2023